TUMOR TARGETING AND TISSUE BIODISTRIBUTION OF RO7122290, A NOVEL FAP-TARGETED 4-1BB (CD137) AGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, USING [89ZR]-RO7122290 AS A PET TRACER

Maria Jose Garcia Velloso; Ivan Penuelas; Mariano Ponz-Sarvise; Miguel Sanmamed; Maria Rodriguez-Ruiz; Ignacio Melero; Danielle Vugts; Ronald Boellaard; Marc Huisman; Guus van Dongen; Ernesto Guarin; Florian Heil; Maurizio Ceppi; Marta Canamero; Camilla Matheisen; Francois Iglesias; Radoiane Helbaj; Oliver Krieter; Michael Hettich

doi:https://doi.org/10.1136/jitc-2020-SITC2020.0286

TUMOR TARGETING AND TISSUE BIODISTRIBUTION OF RO7122290, A NOVEL FAP-TARGETED 4-1BB (CD137) AGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, USING [89ZR]-RO7122290 AS A PET TRACER

Maria Jose Garcia Velloso, Ivan Penuelas, Mariano Ponz-Sarvise, Miguel Sanmamed, Maria Rodriguez-Ruiz, Ignacio Melero, Danielle Vugts, Ronald Boellaard, Marc Huisman, Guus van Dongen, Ernesto Guarin, Florian Heil, Maurizio Ceppi, Marta Canamero, Camilla Matheisen, Francois Iglesias, Radoiane Helbaj, Oliver Krieter, Michael Hettich

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	A175-A175
Journal	Journal for Immunotherapy of Cancer
Volume	8
DOIs	https://doi.org/10.1136/jitc-2020-SITC2020.0286
Publication status	Published - Nov 2020

Access to Document

https://doi.org/10.1136/jitc-2020-SITC2020.0286

Cite this

Garcia Velloso, M. J., Penuelas, I., Ponz-Sarvise, M., Sanmamed, M., Rodriguez-Ruiz, M., Melero, I., Vugts, D., Boellaard, R., Huisman, M., van Dongen, G., Guarin, E., Heil, F., Ceppi, M., Canamero, M., Matheisen, C., Iglesias, F., Helbaj, R., Krieter, O., & Hettich, M. (2020). TUMOR TARGETING AND TISSUE BIODISTRIBUTION OF RO7122290, A NOVEL FAP-TARGETED 4-1BB (CD137) AGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, USING [89ZR]-RO7122290 AS A PET TRACER. Journal for Immunotherapy of Cancer, 8, A175-A175. https://doi.org/10.1136/jitc-2020-SITC2020.0286

@article{010cdff364b34b79999267d292a0cc37,

title = "TUMOR TARGETING AND TISSUE BIODISTRIBUTION OF RO7122290, A NOVEL FAP-TARGETED 4-1BB (CD137) AGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, USING [89ZR]-RO7122290 AS A PET TRACER",

author = "{Garcia Velloso}, {Maria Jose} and Ivan Penuelas and Mariano Ponz-Sarvise and Miguel Sanmamed and Maria Rodriguez-Ruiz and Ignacio Melero and Danielle Vugts and Ronald Boellaard and Marc Huisman and {van Dongen}, Guus and Ernesto Guarin and Florian Heil and Maurizio Ceppi and Marta Canamero and Camilla Matheisen and Francois Iglesias and Radoiane Helbaj and Oliver Krieter and Michael Hettich",

year = "2020",

month = nov,

doi = "https://doi.org/10.1136/jitc-2020-SITC2020.0286",

language = "English",

volume = "8",

pages = "A175--A175",

journal = "Journal for Immunotherapy of Cancer",

issn = "2051-1426",

publisher = "BioMed Central",

}

Garcia Velloso, MJ, Penuelas, I, Ponz-Sarvise, M, Sanmamed, M, Rodriguez-Ruiz, M, Melero, I, Vugts, D , Boellaard, R, Huisman, M, van Dongen, G, Guarin, E, Heil, F, Ceppi, M, Canamero, M, Matheisen, C, Iglesias, F, Helbaj, R, Krieter, O & Hettich, M 2020, 'TUMOR TARGETING AND TISSUE BIODISTRIBUTION OF RO7122290, A NOVEL FAP-TARGETED 4-1BB (CD137) AGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, USING [89ZR]-RO7122290 AS A PET TRACER', Journal for Immunotherapy of Cancer, vol. 8, pp. A175-A175. https://doi.org/10.1136/jitc-2020-SITC2020.0286

TUMOR TARGETING AND TISSUE BIODISTRIBUTION OF RO7122290, A NOVEL FAP-TARGETED 4-1BB (CD137) AGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, USING [89ZR]-RO7122290 AS A PET TRACER. / Garcia Velloso, Maria Jose; Penuelas, Ivan; Ponz-Sarvise, Mariano et al.
In: Journal for Immunotherapy of Cancer, Vol. 8, 11.2020, p. A175-A175.

Research output: Contribution to journal › Meeting Abstract › Academic

TY - JOUR

T1 - TUMOR TARGETING AND TISSUE BIODISTRIBUTION OF RO7122290, A NOVEL FAP-TARGETED 4-1BB (CD137) AGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, USING [89ZR]-RO7122290 AS A PET TRACER

AU - Garcia Velloso, Maria Jose

AU - Penuelas, Ivan

AU - Ponz-Sarvise, Mariano

AU - Sanmamed, Miguel

AU - Rodriguez-Ruiz, Maria

AU - Melero, Ignacio

AU - Vugts, Danielle

AU - Boellaard, Ronald

AU - Huisman, Marc

AU - van Dongen, Guus

AU - Guarin, Ernesto

AU - Heil, Florian

AU - Ceppi, Maurizio

AU - Canamero, Marta

AU - Matheisen, Camilla

AU - Iglesias, Francois

AU - Helbaj, Radoiane

AU - Krieter, Oliver

AU - Hettich, Michael

PY - 2020/11

Y1 - 2020/11

U2 - https://doi.org/10.1136/jitc-2020-SITC2020.0286

DO - https://doi.org/10.1136/jitc-2020-SITC2020.0286

M3 - Meeting Abstract

SN - 2051-1426

VL - 8

SP - A175-A175

JO - Journal for Immunotherapy of Cancer

JF - Journal for Immunotherapy of Cancer

ER -

Garcia Velloso MJ, Penuelas I, Ponz-Sarvise M, Sanmamed M, Rodriguez-Ruiz M, Melero I et al. TUMOR TARGETING AND TISSUE BIODISTRIBUTION OF RO7122290, A NOVEL FAP-TARGETED 4-1BB (CD137) AGONIST, IN PATIENTS WITH ADVANCED SOLID TUMORS, USING [89ZR]-RO7122290 AS A PET TRACER. Journal for Immunotherapy of Cancer. 2020 Nov;8:A175-A175. doi: https://doi.org/10.1136/jitc-2020-SITC2020.0286